New Grant Encourages Advancement in Pediatric Psoriasis Research

Portland, Ore. (December 6, 2017) —The National Psoriasis Foundation (NPF), in collaboration with the Pediatric Dermatology Research Alliance (PeDRA), announces the 2018 Pediatric Psoriasis Challenge Grant, to foster advancement in pediatric psoriasis research. The grant, which consists of as many as two $75,000 awards, encourages the advancement of innovative research in pediatric psoriasis and supports projects that address any aspect of the disease, including cause, diagnosis, treatment options and related comorbidities.

“A psoriasis diagnosis can be devastating for anyone; however, our youngest patient population faces the most challenges,” said Michael Siegel, Ph.D., senior vice president of research and clinical affairs, NPF. “This grant aims to fund research that will lead to solutions that minimize the burden of psoriasis and enable children living with the disease to thrive and ultimately realize an improved quality of life.”

Pediatric psoriasis carries dynamic challenges that can influence children physically, socially and emotionally, affecting their overall quality of life. Additionally, managing pediatric psoriasis can be tricky, as there are still fewer approved therapies available for treating pediatric patients than there are for adults.

“We are thrilled to align with patients and the NPF on advancing pediatric studies, and to be able to leverage our strong research network for this important initiative,” said Sheila Rittenberg, executive director, PeDRA.

Psoriasis is more than skin deep. According to a study published in the British Journal of Dermatology, the overall rate of comorbid medical conditions in pediatric patients under the age of 20 is double that of their peers who do not have psoriasis. Children with psoriasis are at higher risk for a range of cardiovascular and metabolic comorbidities, especially obesity, as well as dyslipidemia, diabetes, and hypertension. Of equal importance, pediatric patients may suffer from poor self-esteem, depression and anxiety, which can persist into adulthood.

Staying true to its mission of finding a cure for psoriatic disease and improving the lives of those affected, this grant complements NPF programs and services already offered to pediatric and youth patients, and their families. Some of those programs and services include the NPF Patient Navigation Center, which provides direct assistance to children and their parents; Our Spot, a website offering age-appropriate resources for youth and teens living with psoriatic disease; and the NPF Youth Ambassador Program, which gives young people living with psoriatic disease opportunities to engage with others with the disease.

With the 2018 Pediatric Psoriasis Challenge Grant, NPF continues to support pediatric psoriatic patients by funding innovative research on psoriatic disease and related comorbidities. To learn more about the grant visit: www.psoriasis.org/grants


About the National Psoriasis Foundation

Serving its community through more than 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. The NPF mission is to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune-mediated disease. As part of that effort, NPF created its Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. To date, NPF has funded more than $21 million in research grants and fellowships that help drive discoveries that may lead to more and better treatments and ultimately a cure. Learn more at www.psoriasis.org.